Drugs for acute myeloid leukemia

Drugs used in the treatment of AML include chemotherapeutic drugs (e.g., mitoxantrone, cytarabine, etc.) and targeted drugs (e.g., vinpocetine, enzidipine, etc.). 1. Chemotherapeutic drugs: mainly include mitoxantrone, desmethoxylated erythromycin, cytarabine, aclarubicin, and hypertriglycerides. The most common adverse effects of chemotherapeutic drugs are gastrointestinal reactions (such as nausea, vomiting, etc.), bone marrow suppression (such as anemia, thrombocytopenia, etc.). 2. Targeted drugs: mainly Giritinib (FLT3 inhibitor), Vinaclat, Midostaurin (FLT3 inhibitor), Everolimus (IDH1 inhibitor), Gituzumab (CD33), Ensildipine (IDH inhibitor), Gilitinib, Sorafenib and so on. Common side effects of targeted drugs include itchy skin, rash, and gastrointestinal reactions. All of the above medications should be used under a doctor’s supervision and avoid self-medication.